NewsRx

Search our medical news database

Vaccine Development

Oil adjuvants are making a comeback in therapeutic vaccines

Published in Vaccine Weekly, June 21st, 2006

Oil adjuvants are making a comeback in therapeutic vaccines.

According to a report from France, "Water-in-oil emulsions represent one of the new promising generations of adjuvants for immunotherapy. Fifty years ago, incomplete Freund adjuvant (IFA) was used in clinical trials for prophylactic vaccines such as poliomyelitis or influenza vaccine because of its strong potency. However, even if the quality of the raw materials has been improved to avoid secondary reactions, the risk-benefit ratio was not favorable to its use for prophylactic vaccines. Moreover, emulsions were highly viscous with poor stability."

"The development of new adjuvants concepts...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook